Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
16Feb
Related Posts
07Oct
Delegation visit from Swissnex in India
We were pleased to host a delegation from Swissnex in India to... read more
05Apr
Demystifying Rare Genetic Diseases – GNE Myopathy Poster launch
The Demystifying Rare Genetic Diseases project kicks off with the launch of... read more
06Jul
The pursuit of a cure for hemophilia – Vasanth Thamodaran
History books, from as early as 2nd century AD, indicate knowledge of a... read more
21Apr
On rising Covid-19 cases
Mask is ‘super vaccine’, COVID-19 still a threat, say scientists "Hyderabad is recording... read more
28Jul
DBT/Wellcome Trust India Alliance Early Career Fellowship to Dr. Shivranjani Moharir
We are pleased to announce that Dr. Shivranjani Moharir, Senior Scientist, TIGS... read more
04May
COVID-19 is airborne; Masks still essential to avoid the spread of virus, Collaborative Study reveals
In a collaborative study, it is found that, novel Coronavirus is airborne... read more
03Oct
MoU signing with Institute of Bioinformatics and Applied Biotechnology (IBAB)
We are glad to announce an institutional MoU with Institute of Bioinformatics... read more
13Mar
Key insights of REDRESS 2023 featured in Biospectrum India
Rare Genetic Diseases Research Summit (REDRESS) 2023, an indigenous and recurrent platform... read more
10Feb
OneHealth national agenda meeting
A meeting at Indian Institute for Science (IISc), involving various academic, research... read more
14Feb
Press Release: Researchers Unveil Detailed Genome of Malaria Mosquito Vector
New ‘gold standard’ reference genome reveals thousands of new genes vital for... read more